Intellia Therapeutics (NTLA) Stock Price, Quote, News & History | Benzinga

Intellia Therapeutics Inc (NTLA) Stock Price, Quote, News & History

NTLANASDAQ

Trade with Public

Trade with Public

$15.25

-0.50-3.17%

At close: Jun 23, 5:00 PM EST

$15.45

0.201.31%

After Hours: 5:21 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$15.43

Close

$15.25

Volume / Avg.

4.88M / 6.34M

Day Range

$15.06 - $15.93

52 Wk Range

7.95 - 28.25

Market Cap

$2.16B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

43.78%

Days to Cover

9.23

Recent Intellia Therapeutics Inc News

Intellia's One-Time Gene Editing Therapy Gains Ground Against Rivals In Rare Swelling Disorder

Intellia shares rise after new Phase 3 lonvo-z data showed significant reductions in HAE attacks and reinforced its regulatory outlook.

Vandana Singh

Cathie Wood Trims Chip Exposure, Adds To AI Platforms—ETF Investors Watch Positioning

Cathie Wood trims chip exposure and adds AI platform and biotech bets, offering ETF investors insight into shifting AI positioning.

Chandrima Sanyal

Intellia Therapeutics FDA Rolling Application For Gene Therapy Puts Hype To Test

Intellia stock rises after BLA filing for lonvo-z; Phase 3 data show 87% attack reduction as traders weigh momentum and key technical levels.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-363.15M

Investing Cash Flow (TTM)

200.01M

Financing Cash Flow (TTM)

165.06M

Free Cash Flow (TTM)

-363.63M

Capital Expenditure (TTM)

-473.00K

Net Change in Cash (TTM)

1.92M

Analyst Trends and Forecast

5

1

Mar

2

2

1

Apr

2

2

May

2

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.2

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.91B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

28.70

PB Ratio (TTM)

3.54

Earnings Yield % (TTM)

-22.35%

Earnings Yield % (FWD)

-19.87%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.44

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$134.70M

Debt to Equity

0.13

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$15.43

Close

$15.25

Volume / Avg.

4.88M / 6.34M

Day Range

$15.06 - $15.93

52 Wk Range

7.95 - 28.25

Market Cap

$2.16B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

43.78%

Days to Cover

9.23

About

Sector

Health Care

Industry

Biotechnology

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a rev...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Intellia Therapeutics (NTLA) stock?

A

You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Intellia Therapeutics (NTLA) competitors?

A

There are no as such competitors for Intellia Therapeutics.

Q

What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?

A

Intellia Therapeutics has a consensus price target of $25.26.

Q

What is the current price for Intellia Therapeutics (NTLA)?

A

The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $15.45 last updated June 23, 2026 at 5:21 PM EDT.

Q

Does Intellia Therapeutics (NTLA) pay a dividend?

A

There are no upcoming dividends for Intellia Therapeutics.

Q

When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?

A

Intellia Therapeutics does not have any upcoming earnings scheduled.

Q

Is Intellia Therapeutics (NTLA) going to split?

A

There is no upcoming split for Intellia Therapeutics.

Q

What sector and industry does Intellia Therapeutics (NTLA) operate in?

A

Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.